Introduction {#s1}
============

Toxins-antitoxins (TAs) were discovered in the early 1980s and, later on, their cellular function was extensively studied especially in the past two decades. However, until now the world of TAs is still perplexing. TAs are found abundantly in prokaryotes, especially in free-living bacteria, as well as in archaea, and probably in fungi but so far, not in other eukaryotes (Pandey and Gerdes, [@B55]). In general, a TA locus consists of two genes organized as an operon, with the antitoxin gene, which is generally precedes the toxin gene, encoding either an untranslated RNA or a labile protein that neutralizes the toxicity of its cognate toxin, whereas the toxin gene encodes a toxin protein that binds to the cellular targets and halts essential cell processes. Under certain circumstances such as stress, the system would be triggered by a rapid degradation of the antitoxin, thus liberating the toxin to act on its target. Most known toxins function as RNases (Christensen et al., [@B10]; Nariya and Inouye, [@B50]; Jørgensen et al., [@B32]; Yamaguchi and Inouye, [@B72]), whereas other toxins target essential cellular components such as DNA gyrase (Van Melderen, [@B70]), cell wall (Mutschler et al., [@B49]), and EF-Tu elongation factor (Castro-Roa et al., [@B4]). TAs have been classified into five types, depending on how the antitoxin counteracts the toxin. Type II TAs, in which the antitoxin is a protein that binds avidly to the toxin protein to form an inert complex, are the most widely studied (Makarova et al., [@B44]; Leplae et al., [@B39]). When found on plasmids, TAs function primarily in the stable maintenance of the plasmid, post-segregationally killing off any plasmid-free daughter cells that developed. The functions of the chromosomally-encoded bacterial TAs are still intriguing. They might not be essential, but they have been reported to be involved in a variety of cellular processes related to global stress responses (Christensen et al., [@B10]), programmed cell death (Engelberg-Kulka and Glaser, [@B16]), maintenance of mobilomes (Rowe-Magnus et al., [@B58]; Szekeres et al., [@B66]), persistence (Gerdes and Maisonneuve, [@B23]), biofilm formation (Harrison et al., [@B27]; Soo and Wood, [@B65]), niche colonization (Norton and Mulvey, [@B54]), virulence (Ren et al., [@B57]), phage abortive infection system (Fineran et al., [@B20]; Dy et al., [@B14]), and other important cellular processes (Goeders and Van Melderen, [@B24]). Some bacterial genomes are bountiful in TAs, e.g., Mycobacterium tuberculosis encodes 30 functional TAs (Ramage et al., [@B56]), which makes their intricacy bewildering. The ability of TAs to impart growth control may attribute to the slow growth and dormant state, which are the hallmarks of latent tuberculosis infection (Schifano and Woychik, [@B63]), but the mechanisms involved, and how many TAs may be responsible for these phenotypic traits are still unknown. It is still unclear whether the TAs within the same host could cross-talk. However, some studies have shown that expression of one TA might activate another (Garcia-Pino et al., [@B21]). Whether numerous TAs would provide cumulative or synergistic effect to the cells is something worth to ponder.

*Streptococcus pneumoniae* (the pneumococcus) is a Gram-positive bacterium, pathogenic for humans and responsible for both infections in respiratory tracts as well as invasive infections, and associated with significant morbidity and mortality (Chan et al., [@B5]). Furthermore, clinical isolates of pneumococci show a high degree of variability, probably due to the recombinogenic nature of this bacterium (Claverys et al., [@B11]; Baquero, [@B2]). We had previously identified up to 10 putative Type II pneumococcal TAs based on *in silico* data mining (Chan et al., [@B5]), and three of them had already been proven to be functional, namely *relBE2*, *yefM-yoeB*, and *pezAT* (Chan et al., [@B6]). Here, we have undertaken the validation and characterization of the rest of the putative pneumococcal TAs. We show that *S. pneumoniae* encodes a fourth functional TA operon, *phd-doc*, which corresponds to a *bona fide* TA. Further, we experimentally ruled out some of the predicted pneumococcal gene pairs as typical TAs, since some of these putative toxins turned out to be either non-toxic, or possibly toxic but lacking a cognate antitoxin gene.

Materials and methods {#s2}
=====================

Bacterial strains and growth conditions
---------------------------------------

*S. pneumoniae* R6 (Hoskins et al., [@B28]) and *Escherichia coli* Top10 \[F¯*mcrA*Δ(*mrr-hsd*RMS*-mcrBC*) Φ 80*lacZ*ΔM15 Δ*lacX74 recA1 araD139* Δ(*ara*A*leu*)*7697 galUgalKrpsL*(Str^r^) *endA1 nupG*\] were used as homologous and heterologous hosts for verification of putative TAs from *S. pneumonia* Hungary^19A^-6 (McGee et al., [@B46]) *via* overexpression assays. *S. pneumoniae* R6 was grown in AGCH medium (Lacks, [@B36]) with 0.3 sucrose and 0.2% yeast extract at 37°C in static water bath, and supplemented with erythromycin (1 μg/ml) or tetracycline (1 μg/ml) when the cells harbored recombinant plasmids pLS1ROM-MCS (Lacks et al., [@B37]; Ruiz-Masó et al., [@B60]), or pAST (Ruiz-Cruz et al., [@B59]), respectively. *E. coli* cultures were grown in TY medium (Sambrook and Russel, [@B61]), at 37°C with agitation at 250 rpm (for liquid medium), and supplemented with kanamycin (50 μg/ml) when the cells harbored plasmid pFUS2 (Lemonnier et al., [@B38]) or its derivatives.

DNA manipulations, sequencing, and sequence data analysis
---------------------------------------------------------

DNA manipulations and other molecular biology techniques were done following standard protocols (Sambrook and Russel, [@B61]). *S. pneumoniae* genomic DNA was extracted using the Bacterial Genomic DNA Isolation Kit (Norgen Biotech Corp.). Plasmid DNA from both *S. pneumoniae* and *E. coli* was isolated using the High Pure Plasmid Isolation kit (Roche). However, for *S. pneumoniae*, the plasmid extraction protocols were slightly modified as described (Ruiz-Cruz et al., [@B59]). DNA fragments and PCR products were purified with the NZYGelpure from NZYTech. DNA was sent for automated Sanger sequencing in Secugen S.L., Centro de Investigaciones Biológicas, CSIC, Madrid. DNA sequences were analyzed using the BioEdit Sequence Alignment Editor version 7.0.4.1 (Hall, [@B26]).

Construction of recombinant plasmids with *S. pneumoniae* hungary^19A^-6 putative TAs
-------------------------------------------------------------------------------------

All plasmids and primers used in this study are shown in Table [1](#T1){ref-type="table"}, and the details are described below.

###### 

**Recombinant plasmids used in this study**.

  **Plasmids**                                                               **Descriptions and primers used**
  -------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  pFUS2, (Lemonnier et al., [@B38])                                          A 4.5 kb vector with ori-pBR322 which harbors an arabinose-inducible P~BAD~ promoter upstream of a multiple cloning site
  pFUS2SD                                                                    An SD consensus ′AGGAGG′ was inserted downstream of P~BAD~ promoter and upstream of EcoRI restriction site of pFUS2 plasmid. This recombinant plasmid was used for the cloning of putative toxins from *S. pneumoniae* Hungary^19A^-6 and subsequently for overexpression assays in *E. coli* Top10
  Forward primer: 5′-GGGCTAGC[GAATTC]{.ul}GAGCTC-3′                          
  Reverse primer: 5′-GATC[GAATTC]{.ul}CCTCCTGCTAGCCCAAAAAAACGG-3′            
  pFUS2SD_YoeB                                                               pFUS2SD with *yoeB* from *S. pneumoniae* R6; as positive control in overexpression assays in *E. coli* Top10
  Forward primer: 5′-GATA[GAATTC]{.ul}ATGCTACTCAAGTTTACAGA-3′                
  Reverse primer: 5′-GACA[AAGCTT]{.ul}TTAGTAATGATCTTTAAAGG-3′                
  pFUS2SD_RelE1                                                              pFUS2SD with *relE1* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}GTGCTTAAGATTCGTTATCA-3′                
  Reverse primer: 5′-TCAT[AAGCTT]{.ul}TTAAAATAAATCACTGTGAC-3′                
  pFUS2SD_HicA                                                               pFUS2SD with *hicA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}ATGCCTATGACACAAAAAGA-3′                
  Reverse primer: 5′-TCAT[AAGCTT]{.ul}GCAGGGGCTGAATTTTACAA-3′                
  pFUS2SD_COG2856CA                                                          pFUS2SD with COG2856CA gene from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}ATGGATTTAAGTAATAAAGC-3′                
  Reverse primer: 5′-TTGT[AAGCTT]{.ul}TTATCCTAATGACATTTCCT-3′                
  pFUS2SD_COG2856B                                                           pFUS2SD with COG2856B gene from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}ATGACTGAAAAAGAATTTTC-3′                
  Reverse primer: 5′-TCAT[AAGCTT]{.ul}TTAATTAAGTAGTGCTAAAT-3′                
  pFUS2SD_Ant                                                                pFUS2SD with *ant* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}ATGAACGAACTCATCAACGT-3′                
  Reverse primer: 5′-TCAT[AAGCTT]{.ul}CTAATTAAGGAACTTATCGA-3′                
  pFUS2SD_Bro                                                                pFUS2SD with *bro* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[GAATTC]{.ul}ATGAACGAAATTTTTAATTT-3′                
  Reverse primer: 5′-TCATAAGCTTCTACCCTTCGTCAAATGAGT-3′                       
  pLS1ROM-MCS, (Lacks et al., [@B37]; Ruiz-Masó et al., [@B60])              A 6.8 k vector derived from plasmid pLS1 that harbors a maltose-inducible P~M~ promoter upstream of a multiple cloning site. This plasmid was used for the cloning of putative TAs from *S. pneumoniae* Hungary^19A^-6 and subsequently for overexpression assays in *S. pneumoniae* R6
  pLS1ROM_HicA                                                               pLS1ROM-MCS with *xreA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-AGTA[AAGCTT]{.ul}GGTGTTGTCAGGAGGTAAAA-3′                
  Reverse primer: 5′-AGTC[ACTAGT]{.ul}GAATTTTACAACCCAGCTTG-3′                
  pLS1ROM_RelE1                                                              pLS1ROM-MCS with *xreA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GTAG[AAGCTT]{.ul}ATTTG[ATGGAGG]{.ul}ACTTACG-3′          
  Reverse primer: 5′-AGTC[ACTAGT]{.ul}GAGAACCCCCTTAAAATAGA-3′                
  pLS1ROM_COG2856CA                                                          pLS1ROM-MCS with *xreA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GTAG[AAGCTT]{.ul}GGAAAAAGGT[GAAAGG]{.ul}AATA-3′         
  Reverse primer: 5′-AGTC[ACTAGT]{.ul}TTCCTCATACTTCCCTTGCG-3′                
  pLS1ROM_COG2856B                                                           pLS1ROM-MCS with *xreA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GTAC[AAGCTT]{.ul}AGAAAGCAATAATAATAAAA-3′                
  Reverse primer: 5′-AGTC[ACTAGT]{.ul}TTTTCTCTCCTTTTTTAATT-3′                
  pLS1ROM_XreA                                                               pLS1ROM-MCS with *xreA* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}CTATTATTTGTCAATGAATA-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}TTATTCCTCCAGCAATTGTT-3′              
  pLS1ROM_Ant                                                                pLS1ROM-MCS with *ant* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}TTCAATTGCAAATTATTTAA-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}CTAATTAAGGAACTTATCGA-3′              
  pLS1ROM_XreA-Ant                                                           pLS1ROM-MCS with *xreA-ant* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}CTATTATTTGTCAATGAATA-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}CTAATTAAGGAACTTATCGA-3′              
  pLS1ROM_XreB                                                               pLS1ROM-MCS with *xreB* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}AGCACTAATACCAAGATGAA-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}TTATATTTGATTAGAGAGCC-3′              
  pLS1ROM_Bro                                                                pLS1ROM-MCS with *bro* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}ACACGATTATTCACCCCTTG-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}CTACCCTTCGTCAAATGAGT-3′              
  pLS1ROM_Bro-XreB                                                           pLS1ROM-MCS with *bro-xreB* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GATCCC[AAGCTT]{.ul}ACACGATTATTCACCCCTTG-3′              
  Reverse primer: 5′-GATCCC[ACTAGT]{.ul}TTATATTTGATTAGAGAGCC-3′              
  pLS1ROM_Phd                                                                pLS1ROM-MCS with *phd* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GA[GCGGCCGC]{.ul}AGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3′   
  Reverse primer: 5′-CAGC[GGATCC]{.ul}TCATTTTTCCACCAAAGCTT-3′                
  pLS1ROM_Doc                                                                pLS1ROM-MCS with *doc* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GA[GCGGCCGC]{.ul}AGGAGGAAATCAGATGACAATCTATTTGACAGA-3′   
  Reverse primer: 5′-CAGC[GGATCC]{.ul}TTACTTTTTGACCTTTTCTC-3′                
  pLS1ROM_Phd-Doc                                                            pLS1ROM-MCS with *phd-doc* from *S. pneumoniae* Hungary^19A^-6
  Forward primer: 5′-GA[GCGGCCGC]{.ul}AGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3′   
  Reverse primer: 5′-CAGC[GGATCC]{.ul}TTACTTTTTGACCTTTTCTC-3′                
  pAST, (Ruiz-Cruz et al., [@B59])                                           A 5.5 kb vector derived from plasmid pMV158 that harbors a multiple cloning site between the *E. coli T1T2rrnB* terminator region and the promoter-less *gfp* gene
  pAST_P                                                                     A 231 bp of DNA encompassing the putative promoter of *phd-doc* from *S. pneumoniae* Hungary^19A^-6 was inserted upstream of the *gfp* gene of pAST plasmid.
  Forward primer: 5′-CAGA[GGATCC]{.ul}CTGTTGGAAATGTAGCGTAC-3′                
  Reverse primer: 5′-CAGC[GAGCTC]{.ul}CTGATTTCCTCCTTTGAAGT-3′                
  pAST_PPhd                                                                  A 471 bp of DNA encompassing the putative promoter of *phd-doc* and *phd* gene from *S. pneumoniae* Hungary^19A^-6 was inserted upstream of the *gfp* gene of pAST plasmid.
  Forward primer: 5′-CAGA[GGATCC]{.ul}CTGTTGGAAATGTAGCGTAC-3′                
  Reverse primer: 5′-CAGC[GAGCTC]{.ul}TTGTCATTTTTCCACCAAAG-3′                
  pAST_PPhd                                                                  An 878 bp of DNA encompassing the putative promoter of *phd-doc* and *phd-doc* genes from *S. pneumoniae* Hungary^19A^-6 was inserted upstream of the *gfp* gene of pAST plasmid.
  Forward primer: 5′-CAGA[GGATCC]{.ul}CTGTTGGAAATGTAGCGTAC-3′                
  Reverse primer: 5′-CAGC[GAGCTC]{.ul}TTACTTTTTGACCTTTTCTC-3′                

*The underlined sequences were the restriction sites used for cloning*.

### pLS1ROM-MCS derivatives

Seven putative pneumococcal TA genes from strain Hungary^19A^-6 (GI: 169832377) (Chan et al., [@B5]) were verified in the *S. pneumoniae* homologous host. Plasmid pLS1ROM-MCS (Lacks et al., [@B37]; Ruiz-Masó et al., [@B60]), which was derived from the streptococcal promiscuous plasmid pMV158 (Espinosa, [@B18]), harbors a tight maltose-inducible promoter P~M~. The pneumococcal putative toxin genes along with their Shine-Dalgano (SD) sequences were cloned downstream of promoter P~M~, and then transformed (Lacks, [@B36]) into *S. pneumoniae* R6 for overexpression assays. The seven putative toxin genes were: *relE1* (GI: 169832900), *hicA* (GI: 169834067), genes COG2856CA (GI: 169832377 and 169833989), gene COG2856B (GI: 169832735), *doc* (GI: 169833045), *ant* (*[ant]{.ul}irepressor*) (GI: 169833276; previously known as *bro1*, Chan et al., [@B5]) and *bro* (*[b]{.ul}aculovirus [r]{.ul}epeated [o]{.ul}rfs*) (GI: 169834001; previously known as *bro2*, Chan et al., [@B5]). In the case of the *doc* gene, its SD sequences were not apparent and thus we decided to use the SD sequences of its cognate antitoxin *phd*. Consequently, those which exhibited toxicity to the cells, i.e., *doc*, *ant* and *bro*, were further analyzed by cloning their cognate putative antitoxins *phd* (GI: 169832994), *xreA* (GI: 169832832; previously known as *xre*, Chan et al., [@B5]) and *xreB* (GI: 169834410; previously known as *xre*, Chan et al., [@B5]), as well as both putative TA operons along with their SD, respectively, into pLS1ROM-MCS, and then subjected to overexpression assays.

### pFUS2SD and derivatives

The arabinose-inducible plasmid pFUS2 (Lemonnier et al., [@B38]) was used to construct recombinant plasmids with the seven putative toxins from *S. pneumoniae* Hungary^19A^-6 (as described above) to validate their functionality in *E. coli* heterologous host. Since TA operons are usually co-transcribed and some of the toxin genes which are located downstream of the antitoxin genes do not have an obvious SD sequence, we had constructed plasmid pFUS2SD (this study) by inserting an SD consensus sequence (AGGAGG) downstream of the arabinose-inducible P~BAD~ promoter of pFUS2 by reverse PCR and then self-ligation. This recombinant plasmid was subsequently used for the cloning of the seven putative toxin genes from Hungary^19A^-6 strain. In addition, the known toxin *yoeB* (GI: 15903627) from *S. pneumoniae* R6 was also constructed in pFUS2SD to serve as a positive control (Chan et al., [@B7]). All these genes were inserted at the EcoRI restriction site downstream of the SD sequence, and thus the start codons of all these genes were 6 bp apart from the SD sequence. The recombinant plasmids were transformed into *E. coli* Top10 (Sambrook and Russel, [@B61]) and used to conduct overexpression assays.

### pAST derivatives

To verify the promoter activities and to characterize the transcriptional regulation of the promoter by pneumococcal Phd and Phd-Doc, transcriptional fusions were constructed to measure Green Fluorescent Protein (GFP) fluorescence. Plasmid pAST (Ruiz-Cruz et al., [@B59]), which harbors a promoter-less *gfp* gene was used for this study. The putative promoter of the *phd-doc* operon, the *phd* gene along with its promoter and the *phd-doc* genes along with their promoter were inserted upstream of the *gfp* gene of pAST plasmid, respectively. All the recombinant plasmids were transformed into *S. pneumoniae* R6 and then to evaluate the promoter activities by measuring GFP fluorescence.

Overexpression assays of putative TAs in *S. pneumoniae* and *E. coli*
----------------------------------------------------------------------

Cell cultures of *S. pneumoniae* R6 harboring the different recombinant plasmids were grown in AGCH medium supplemented with 0.3 sucrose and 0.2% yeast extract (Lacks et al., [@B37]) until optical density (OD)~650~ \~ 0.3 and subsequently subcultured to OD~650~ of \~0.02 in the same medium but with addition of 0.2% maltose to induce promoter P~M~. OD of the cultures was measured every hour for 8 h. *E. coli* Top10 with different recombinant plasmids were inoculated in TY medium (Maniatis et al., [@B45]) supplemented with 0.4% glucose to repress expression from the P~BAD~ promoter, and the cells were allowed to grow until OD~600~ of \~0.3. Cells were harvested and washed twice with TY medium, followed by suspension in TY medium to OD~600~ of \~0.02, and then induced with 0.4% arabinose. The assays were repeated three times and the mean values and the standard errors were calculated.

GFP fluorescence assays
-----------------------

To characterize the promoter activities of pneumococcal *phd-doc*, fluorescence assays were conducted as previously described (Ruiz-Cruz et al., [@B59]). Briefly, *S. pneumoniae* carrying recombinant plasmids with various *gfp*-fusions were grown until OD~650~ \~ 0.3. Various volumes of cells (25 μl to 1 ml) were harvested and resuspended in 200 μl 1 × PBS buffer in a 96-well black plate, respectively. Fluorescence was measured with a Varioskan Flash Spectral Scanning Multimode Reader (Thermoscientific) by excitation at 488 nm with a bandwidth of 12 nm and detection of emission at 515 nm. Three independent cultures were analyzed and results of 1 ml of cultures were chosen to show in this manuscript. The cells were also subsequently used for microscopy examination.

Cell morphology examination with phase-contrast and fluorescence microscopy
---------------------------------------------------------------------------

Cells from overexpression assays were harvested at 4 h and 8 h after induction. Cells were washed twice with 1 × PBS, resuspended in 4% paraformaldehyde and fixed at room temperature for 30 min. Cells were again washed once with 1 × PBS buffer and resuspended in the same buffer. The fixed cells were placed on polylysine coated microscope slides, air-dried and mounted with Vectashield (Vector Laboratories) before being covered with cover slides, and sealed with nail polish. The cells were examined under microscope (Olympus CKX41), and pictures were taken at 100 × magnification. To examine pneumococcal cells harboring various *gpf*-fused promoter-*phd-doc* recombinant plasmids, 10 μl of cells in 1 × PBS buffer from Section GFP Fluorescence Assays were viewed under the phase-contrast and fluorescence microscopy. Pictures were taken at 100 × magnification, 200 ms.

Bioinformatics analyses
-----------------------

Genome databases in NCBI (<http://www.ncbi.nlm.nih.gov/>) and Pfam (<http://pfam.sanger.ac.uk/>) were used for bioinformatics analyses. Sequence alignments were conducted using web tool Clustal Omega (<http://www.ebi.ac.uk/Tools/msa/clustalo/>) and the BioEdit Sequence Alignment analytical software, whereas neighbor-joining phylogenetic trees were generated with Composition Vector Tree Version 2 (<http://tlife.fudan.edu.cn/cvtree/>) and MEGA6.05. A web-based resource for bacterial integrative and conjugative elements (ICEs) termed ICEberg (<http://db-mml.sjtu.edu.cn/ICEberg/>) (Bi et al., [@B3]) was used to detect the presence of TAs in pneumococal ICEs. PHAST (PHAge Search Tool) (<http://phast.wishartlab.com/>) (Zhou et al., [@B74]) was used to identify TAs in prophage sequences within pneumococcal genomes. In the case of strains, whose sequence types (STs) were not directly available, sequences of seven loci used in the multilocus sequence typing (MLST) scheme (Enright and Spratt, [@B17]) were retrieved from genomic data and submitted to the online database <http://pubmlst.org/spneumoniae/> (28th August 2014, date last accessed) to obtain allele numbers and STs. Position of the STs was then analyzed for all strains within the population snapshot, constructed based on the content of the whole MLST database (28th August 2014, date last accessed) using the eBURST approach (Feil et al., [@B19]) at <http://eburst.mlst.net/> and resulting clonal complexes (CCs) were named based on the predicted founder of the group. The largest observed CC, including ST156 as a proposed primary founder, was additionally divided into lineages named according to the predicted secondary founders.

Results and discussion
======================

Verification of the putative TAs from *S. pneumoniae* hungary^19A^-6 in *S. pneumoniae* R6 and in *E. coli* Top10
-----------------------------------------------------------------------------------------------------------------

Between 4 and 10 putative TAs were found in our previous *in silico* analysis of *S. pneumoniae* genomes (Chan et al., [@B5]). Genes of the putative TAs analyzed here were derived from the Hungary^19A^-6 strain. It is a pathogenic strain, which harbors all 10 putative TA pairs, thus covering most (if not all) of the putative pneumococcal TAs reported to date. Three out of the 10 TA operons, namely the R6 strain *relBE2*, *yefM-yoeB* and *pezAT*, had been previously shown to encode functional TAs in *S. pneumoniae* and also in *E. coli* (Nieto et al., [@B52], [@B51]; Khoo et al., [@B34]). Thus, these three pairs were not included here, with the exception of the *yoeB* toxin gene that was used as a positive control for the overexpression assays in the *E. coli* host.

The functionality of the seven putative toxins was first analyzed in their natural host *S. pneumoniae* and the ones that retarded cell growth were further analyzed with their cognate antitoxins. In the case of the pneumococcal *doc* gene, the construction of plasmid pLS1ROM-MCS harboring *doc* had a mutation at the SD in which ′AGG[A]{.ul}GG′ was changed to ′AGG[C]{.ul}GG′. However, this mutation did not hinder Doc protein to exhibit its toxicity to the cell. Overproduction of Doc had strongly retarded the growth of *S. pneumoniae* despite the growth resumed after 6 h (Figure [1A](#F1){ref-type="fig"}). Nonetheless, its toxicity could be clearly neutralized by co-expression of its cognate antitoxin Phd *in cis* (Figure [1B](#F1){ref-type="fig"}). This finding demonstrated that the pneumococcal *phd-doc* pair constitutes a *bona fide* functional TA. For Ant and Bro, cell growth was also inhibited when the proteins were overproduced, respectively, albeit less toxic than Doc (Figure [1A](#F1){ref-type="fig"}). Growth of *S. pneumoniae* cells resumed after a few hours of induction of the toxins (Figure [1A](#F1){ref-type="fig"}), indicating the toxicity was temporal. Unexpectedly, co-expression of their presumptive cognate antitoxins XreA and XreB did not neutralize the toxicity of Ant and Bro, respectively (Figure [1B](#F1){ref-type="fig"}). Expression of XreA and XreB alone was not toxic to the cells, but intriguingly, the pairs XreA-Ant and Bro-XreB seemed to be slightly more toxic to the cells, compared to the Ant and Bro toxins alone (Figure [1B](#F1){ref-type="fig"}). Conversely, overproduction of the rest of the putative pneumococcal toxins HicA, RelE1, COG2856CA, and COG2856B had no effect on the growth of *S. pneumoniae* (Figure [1A](#F1){ref-type="fig"}).

![**Overexpression of pneumococcal putative TAs. (A)** Overexpression of pneumococcal putative toxins in homologous host *S. pneumoniae* had shown that HicA, RelE1, COG2856CA, and COG2856C were not harmful to the cells; whereas overexpression of Doc, Ant and Bro had thwarted cell growth but resumed a few hours albeit slowly. **(B)** Since Doc, Ant and Bro were toxic to the cells, they were thus further analyzed to ensure if their putative cognate antitoxins were functional as well in *S. pneumoniae host*. For Doc, co-expression of its cognate antitoxin Phd *in cis* had neutralized the Doc toxicity to the cell, signifying Phd-Doc is a functional TA. On the other hand, overexpression of Ant and Bro repressed the growth of the cells but co-expression of their cognate putative antitoxins XreA and XreB, respectively, were not able to neutralize the toxic effect of the toxins, and instead more toxic to the cells. Note that XreA or XreB alone was inert to the cells. Thus, we have ruled out that XreA-Ant and Bro-XreB are typical TAs. **(C)** Overexpression assays in heterologous host *E. coli*. Similar to the natural host *S. pneumoniae*, overexpression of pneumococcal putative toxins HicA, RelE1, COG2856CA, and COG2856C did not affect cell growth. Unfortunately we were not able to construct doc toxin in pFUS2SD plasmid likely due to its high toxicity. YoeB from strain R6, which is a known functional pneumococcal toxin (Nieto et al., [@B51]; Chan et al., [@B7]) was used as a positive control (pFUS2SD_YoeB), whereas pFUS2SD without insert served as a negative control. As with the pneumococcal YoeB toxin, overexpression of pneumococcal Ant and Bro inhibited growth of *E. coli* and no recovery was observed even after 8 h of incubation, which was in contrary to the results in *S. pneumoniae*, in which cell growth was resumed a few hours after toxins overproduction.](fmicb-05-00677-g0001){#F1}

In the case of the heterologous host *E. coli*, as in their native host *S. pneumoniae*, overexpression of HicA, RelE1, COG2856CA, and COG2856B were inert to the cells (Figure [1C](#F1){ref-type="fig"}). We were unable to obtain the recombinant plasmid of pFUS2SD with the putative pneumococcal toxin *doc* gene, most likely because of its high toxicity to the host. As it was observed for YoeB, overexpression of the Ant and Bro proteins led to suppression of the growth of *E. coli*; moreover, in contrast to *S. pneumoniae*, no indication that the cultures resumed growth was found even after 8 h of incubation, indicating that both proteins were very toxic to the host (Figure [1C](#F1){ref-type="fig"}).

We conclude that out of the seven gene pairs that we had investigated here, only Phd-Doc was demonstrated to be a *bona fide* pneumococcal TA. Concerning Ant and Bro, overexpression of each of these proteins inhibited growth of both *S. pneumoniae* and *E. coli*; however, the products of their adjacent genes XreA and XreB were unable to counteract their toxicity, respectively. Therefore, we do not classify them as typical TA pairs. Thus, we have re-evaluated the number of functional *bona fide* TAs for the 48 pneumococcal strains whose genomic sequences are available in the NCBI genome databases (Table [2](#T2){ref-type="table"}, see below).

###### 

**Distribution of sequence types, clonal complexes, and functional TAs in *S. pneumonia***.

  **Strain (*N* = 48)**   **Sequence type**   **Clonal complex**   **Phd-Doc**   **YefM-YoeB**                       **PezAT**   **RelBE2[^a^](#TN1a){ref-type="table-fn"} (type)**   **Total**
  ----------------------- ------------------- -------------------- ------------- ----------------------------------- ----------- ---------------------------------------------------- -----------
  INV200                  9                   15                   1             1                                   1           1 (II)                                               4
  BS397                   13                  15                   1             1                                   1           1 (II)                                               4
  BS455                   2011                15                   1             1                                   1           1 (II)                                               4
  BS457                   13                  15                   1             1                                   1           1 (II)                                               4
  BS458                   13                  15                   1             1                                   1           1 (II)                                               4
  SP-BS293                13                  15                   1             1                                   1           1 (II)                                               4
  SP14-BS292              13                  15                   1             1                                   1           1 (II)                                               4
  CGSP14                  15                  15                   1             1                                   2           1 (II)                                               5
  AP200                   62                  62                   1             1                                               1 (II)                                               3
  MLV-016                 62                  62                   1             1                                               1 (II)                                               3
  SP11-BS70               62                  62                   1             1                                               1 (II)                                               3
  G54                     63                  63                   1                                                             1 (II)                                               2
  JJA                     66                  66                   1             1                                   1           2 (II & V)                                           5
  ATCC 700669             81                  81                   1                                                 2           2 (II&V)                                             5
  670-6B                  90                  90                   1             1                                   1           1 (II)                                               4
  GA41317                 2705                100                                1                                               1 (II)                                               2
  OXC141                  180                 180                  1                                                 1           1 (II)                                               3
  SP3-BS71                180                 180                  1                                                 1           1 (II)                                               3
  CDC1087-00              191                 191                  1             1                                               1 (II)                                               3
  CDC3059-06              199                 199                  1                                                 1           2 (I&V)                                              4
  TIGR4                   205                 205                  1             1                                   1           1 (I)                                                4
  P1031                   303                 217                  1                                                 2           2 (II&VI)                                            5
  CDC0288-04              220                 218                                1                                   1           1 (IV)                                               3
  GA41301                 242                 242                  1             1                                   1           2 (II&V)                                             5
  70585                   289                 289                  1                                                 1           1 (II)                                               3
  INV104                  227                 306                  1             [^b^](#TN1b){ref-type="table-fn"}               1 (II)                                               2
  GA47901                 304                 306                  1                                                             1 (II)                                               2
  GA04375                 236                 320                  1                                                             1 (IV)                                               2
  Taiwan19F-14            236                 320                  1                                                             1 (IV)                                               2
  str. Canada MDR_19A     320                 320                  1                                                             1 (II)                                               2
  str. Canada MDR_19F     320                 320                  1                                                             1[^c^](#TN1c){ref-type="table-fn"}                   2
  TCH8431/19A             320                 320                  1                                                             1 (IV)                                               2
  SP19-BS75               485                 395                  1             1                                   1           1 (II)                                               4
  SP23-BS72               37                  439                                1                                   1           1 (II)                                               3
  SP6-BS73                460                 460                  1                                                 1           1 (I)                                                3
  GA17545                 9057                1536                 1                                                             1 (II)                                               2
  CDC1873-00              376                 2090                 1             1                                   1           2 (II&V)                                             5
  GA47368                 1339                2090                 1             1                                   1           2 (II&V)                                             5
  CCRI 1974               124                 L_124                1                                                             1 (II)                                               2
  CCRI 1974M2             124                 L_124                1                                                             1 (II)                                               2
  SP14-BS69               124                 L_124                1                                                 1           1 (II)                                               3
  SP18-BS74               146                 L_146                1                                                             1 (II)                                               2
  GA17570                 156                 L_156                1             1                                   1           1 (III)                                              4
  SP195                   156                 L_156                1             1                                   1           1 (III)                                              4
  SP9-BS68                1269                L_162                1             1                                   1           1 (III)                                              4
  Hungary 19A-6           268                 L_176                1             1                                   1           1 (II)                                               4
  D39                     595                 singleton                          1                                   1           1 (I)                                                3
  R6                      595                 singleton                          1                                   1           1 (I)                                                3

*The organization types (I--VI) of the RelBE2-TA are indicated within parenthesis*.

*There is a stop codon within YoeB (only 15 amino acid residues are translated) of strain INV104, and thus YefM-YoeB of this strain was excluded in this table*.

*Data not available for analyses*.

The pneumococcal Phd-doc: the fourth functional TA pair in *S. pneumoniae*
--------------------------------------------------------------------------

As mentioned above, the pneumococcal Doc was shown to be toxic to its natural host, and co-expression of the cognate Phd antitoxin was able to counteract the toxicity of Doc. The pneumococcal *phd-doc* gene pair was present in a single copy in almost all the genomes of pneumococcal strains examined (43 out of 48 strains; Table [2](#T2){ref-type="table"}) (Chan et al., [@B5]). The *phd-doc* genes are structured as an operon, which was consistently surrounded by genes encoding Type I restriction-modification systems; further, a gene that encodes a putative integrase/recombinase was also conserved downstream of *doc* (Figure [2A](#F2){ref-type="fig"}). However, the genomic context of *phd-doc* was not entirely conserved since, in some strains, transposases were also evident further downstream. The pneumococcal *phd* antitoxin and *doc* toxin genes overlap by four nucleotides and both genes are likely co-transcribed from a single promoter located upstream of *phd* (Figure [2A](#F2){ref-type="fig"}). An inverted repeat of 8 nt (GTAA·TTAC) was identified, which partly covered the −35 consensus sequences (Figure [2A](#F2){ref-type="fig"}). This differs from the promoter of *phd-doc* of bacteriophage P1, in which two palindrome sequences (TGTGT·ACACA and CGAGT·ACACG) were found to be located between the −10 consensus sequence and the start codon of Phd, with one of the palindromes overlapping the SD (Magnuson et al., [@B41]). We postulate that the inverted repeat would function as the operator where the pneumococcal Phd antitoxin binds to repress its own transcription, as in other TAs (Magnuson et al., [@B41]; Tian et al., [@B68]; Kedzierska et al., [@B33]). To test the regulation of transcription of pneumococcal Phd-Doc, we constructed a set of pneumococcal plasmids based on the pAST promoter-probe vector that harbors the *gfp* gene (Ruiz-Cruz et al., [@B59]). Thus, transcriptional fusions allowed us to measure the *phd-doc* promoter. In addition, and to demonstrate whether Phd antitoxin and the Phd-Doc pair regulate their transcription, either the antitoxin or the TA pair was fused to the promoter-less gene encoding GFP. Measurement of the levels of fluorescence showed that indeed the promoter region resulted in GFP expression of \~8 arbitrary units, which were slightly repressed by synthesis of the antitoxin (\~6 arbitrary units) and repressed further to \~1 arbitrary units (down to nearly basal levels \~0.1 arbitrary units) by the joint production of the Phd-Doc pair (Figure [2B](#F2){ref-type="fig"}). In agreement to these results, observation of these cells under phase-contrast and fluorescence microscopy also demonstrated that the fluorescence was not much different for cells harboring promoter-*gfp* and promoter-*phd-gfp*; whereas the fluorescence of cells harboring promoter-*phd-doc-gfp* was visibly lower (Figure [2C](#F2){ref-type="fig"}). Employment of the GFP reporter to detect TA activation was previously shown for the *Salmonella sehAB* operon (De La Cruz et al., [@B13]). In our case, it has turned out to be a simple and reliable way to show auto-repression of the *phd-doc* operon. Further, it could be used for any of the TA to be tested and also to perform *in vivo* studies on conditions that trigger any particular TA. To our understanding, this is the first time that this strategy is performed for a Gram-positive bacterium.

![**Gene organization and expression of the pneumococcal *phd-doc* locus. (A)** The pneumococcal *phd-doc* is surrounded by genes that encode Type I restriction-modification (RM) proteins and integrase/recombinase. The pneumococcal *phd* antitoxin gene is located upstream of its cognate toxin gene *doc*, and both genes overlap by 4 nucleotides. A promoter and a Shine-Dalgano (SD) were identified upstream of *phd*, and an inverted repeat (denoted by arrows) was found overlapping the −35 sequences (boxed); the −10 region of the putative promoter and the SD sequences are also boxed. The stop codon of Phd is underlined and the start codon of Doc is indicated in overline. **(B)** Expression and self-regulation of the *phd-doc* operon. Cultures (1 ml) of *S. pneumoniae* R6 cells harboring recombinant plasmids were grown until an OD~650~ \~0.3. Cells were harvested, resuspended in 1 × PBS buffer and their fluorescence was measured. Plasmids used were: pAST_P, harboring only the promoter of the operon; pAST_PPhd, harboring the promoter and the *phd* gene; pAST_PPhdDoc, harboring the entire *phd-doc* operon, and the promoter-less *gfp* plasmid vector, pAST, used as control. *SE* (average of three independent experiments) are indicated. **(C)** Cells examination under phase-contrast and fluorescence microscopy. The GFP level for cells harboring pAST_P (a) and pAST_PPhd (b) did not show much difference; whereas GFP level for pAST_PPhdDoc (c) was visibly lower, which is coincided with the fluorescence measurement. Cells harboring plasmid pAST served as negative control.](fmicb-05-00677-g0002){#F2}

Like other Doc homologs, the pneumococcal Doc has a Fic ([f]{.ul}ilamentation [i]{.ul}nduced by cyclic AMP) domain (Utsumi et al., [@B69]) at the N-terminal moiety. In general, the conserved Fic motif, HxFx(D/E)GNGRxxR (Engel et al., [@B15]; Goepfert et al., [@B25]), possesses adenylylation (or "AMPylation") activity (Itzen et al., [@B30]; Woolery et al., [@B71]). By comparison, the consensus residues of the Fic motifs in all Doc toxins are slightly different, HxFx(D/N)(A/G)NKR (Cruz et al., [@B12]), as is the pneumococcal Fic motif HVFANANKR. The target of the Doc toxin from bacteriophage P1 (Magnuson and Yarmolinksy, [@B42]) was revised recently, in which Doc was reported to be a new type of protein kinase \[instead of AMPylating like other Fic proteins (Kinch et al., [@B35]) or obstructing ribosomes (Liu et al., [@B40])\] that inhibits bacterial translation by phosphorylating the conserved threonine (Thr382) of the translation elongation factor EF-Tu, thereby rendering it unable to bind aminoacylated tRNAs (Castro-Roa et al., [@B4]; Cruz et al., [@B12]). Interestingly, it was also demonstrated that the Phd antitoxin can only block the *de novo* phosphorylation of EF-Tu, but cannot revert it, and dephosphorylation of EF-Tu was probably catalyzed by the Doc toxin itself (Castro-Roa et al., [@B4]). This finding coincided with our observation, in which the inhibition of growth mediated by the pneumococcal Doc toxin was slowly relieved a few hours after overexpression (Figure [1B](#F1){ref-type="fig"}). It had been shown that ectopic overexpression of Doc in *E. coli* might lead to Lon-dependent activation of RelE to exhibit its mRNA cleavage activity (Garcia-Pino et al., [@B21]). Since *S. pneumoniae* harbors both RelBE and Phd-Doc TAs, it would be interesting to find out whether both TAs could cross-talk as described by Garcia-Pino et al. ([@B21]).

Morphology of *E. coli* and *S. pneumoniae* cells after toxin overexpression
----------------------------------------------------------------------------

In many cases where overexpressed genes may cause a toxic effect, the bacterial cells change their morphology and may exhibit a phenotype of either filamentation or other gross changes in the cell shape (Scott et al., [@B64]). To test whether overexpression of the various toxins analyzed here had any influence on the cell morphology of *S. pneumoniae* and *E. coli*, cultures were subjected to toxin overexpression under the above conditions, and cells were observed using phase-contrast microscopy. In the case of *S. pneumoniae* no prominent morphological changes were observed for any cells that overexpressed the different toxins (Supplementary Figure [S1](#SM2){ref-type="supplementary-material"}). On the other hand, for *E. coli*, filamentation was observed when Ant or Bro were overexpressed, indicating that the cells were not dividing properly and thus cell growth was impaired (Figures [3C,D](#F3){ref-type="fig"}). The filamentation was not reversible for at least 8 h as inhibition of cell growth by Ant or Bro did not show any sign of resuming even after 8 h (Figure [1C](#F1){ref-type="fig"}). Overexpression of YoeB toxin, which likely an endoribonuclease as its *E. coli* homolog (Christensen et al., [@B8]; Zhang and Inouye, [@B73]), did not result in very obvious differences in morphology when compared to the wild type (Figures [3A,B](#F3){ref-type="fig"}).

![**Morphology of *E. coli* cells under microscope at 100 × magnification after overexpression of the respective pneumococcal toxins**. Morphology of the cells which harbor **(A)** the negative control pFUS2SD, **(B)** the positive control pFUS2SD_YoeB, **(C)** pFUS2SD_Ant and **(D)** pFUS2SD_Bro, were examined after 8 h of overexpression. Filamented cells were observed in cultures overexpressing Ant or Bro, but no prominent differences were found for cells overexpressing YoeB when compared to wild type.](fmicb-05-00677-g0003){#F3}

Other TAs in *S. pneumoniae* and their genetic organization
-----------------------------------------------------------

### The relBE1 operon

A previous study showed that RelE1 of *S. pneumoniae* had no RNase activity (Christensen and Gerdes, [@B9]), but the cell growth profile after overexpression of RelE1 was not assessed. Here, we confirmed that expression of RelE1 was not detrimental to its homologous host or to the heterologous host *E. coli* (Figure [1](#F1){ref-type="fig"}) even though RelE1 shared 52% similarity with RelE2 (in the Hungary^19A^-6 strain) which had been demonstrated to be functional (Nieto et al., [@B52]). In spite of the high conservation of both *relB1* and *relE1* in all the strains (not shown), two (R65 and R85) out of five crucial residues responsible for RelE toxicity in *Pyrococcus horikoshii* were missing in the pneumococcal RelE1 (Takagi et al., [@B67]; Nieto et al., [@B53]; Chan et al., [@B5]). In addition, truncation of *relE1* in some strains, such as ATCC 700669 and 70585 was also observed. In general, the gene arrangement around the *relBE1* genes of all the strains was similar, i.e., these genes were flanked upstream by genes that encode DNA polymerase III, elongation factor G and 30s ribosomal proteins, whereas downstream genes were found to be encoding a possible amino peptidase, an integral membrane protein and ribosomal small subunit pseudouridine synthase. In some instances, transposases were identified further upstream of *relB1* (strains ATCC 700669 and INV104). Conservation of the *relBE1* gene pair in many of the pneumococcal genomes could point to a function not related to type II TA, but this remains to be investigated.

### The gene pairs xreA-ant and bro-xreB

These two gene pairs were previously proposed as putative TAs in bioinformatics searches of the *S. pneumoniae* genome (Makarova et al., [@B43]; Chan et al., [@B5]). Overexpression of the pneumococcal Ant and Bro proteins inhibited cell growth in both *S. pneumoniae* and *E. coli*, but co-expression of their putative respective cognate genes *xreA* and *xreB* did not counteract their toxicity. However, we still do not rule out the possibility that Ant and Bro are solitary toxins, similar to the MazF-mx of *M. xanthus*, which lacks the co-transcribed antitoxin (Nariya and Inouye, [@B50]). MrpC, which is expressed from another part of the *M. xanthus* genome, serves as an antitoxin by forming complexes with MazF-mx, and it also positively regulates the MazF-mx expression (Nariya and Inouye, [@B50]).

We made use of a web server designed to identify prophages (PHAST; Zhou et al., [@B74]) to search whether pneumococcal *xreA-ant* and *bro-xreB* gene pairs were located within pneumococcal prophages. We found that they are located within a 94.4 kb intact prophage termed *Streptococcus* phage MM1 of *S. pneumoniae* Hungary^19A^-6 strain (Supplementary material). Analysis with Pfam showed that both Ant and Bro have two domains, respectively: Ant (232 amino acids) has an AntA (AntA/AntB antirepressor) domain at the N-terminal moiety and a phage antirepressor KilAC domain at the C-terminal moiety (Figure [4A](#F4){ref-type="fig"}); whereas Bro (237 amino acids) has a Bro-N domain at the N-terminus and an ORF6C (C-terminal of bacteriophage bIL2850 ORF6) (Iyer et al., [@B31]) domain at the C-terminus (Figure [4B](#F4){ref-type="fig"}). Both KilA and Bro domains are widely prevalent in bacteriophages, bacteria, eukaryotic viruses of the nucleo-cytoplasmic large DNA virus and baculovirus classes (Iyer et al., [@B31]). A study by Kuan et al. showed that the protein ANT8 (ORF8) of lytic corynephage P1201 isolated from *Corynebacterium glutamicum* harbors a Bro domain at the N-terminus and an antirepressor domain at the C-terminal end (<http://research.nchu.edu.tw/upfiles/ADUpload/oc_downmul2272130635.pdf>). In this case, the DNA binding ability of ANT8 was contributed by the Bro domain, whereas overexpression of the antirepressor domain inhibited *E. coli* cell growth and also killed the cells as shown by a decrease in colony forming units. Under microscopic examination, the cells that overexpressed the ANT8 protein became filamentous, with irregular multiple nucleoids, indicating inhibition of cell division, and this result is also in agreement with our findings.

![**The domains of pneumococcal Ant and Bro toxins**. Sequence analyses from Pfam showed that **(A)** pneumococcal Ant harbors two domains, with the AntA domain at the N-terminus and KilAC domain at the C-terminus; whereas **(B)** pneumococcal Bro harbors a Bro-N domain at the N-terminal and an ORF6C domain at the C-terminal.](fmicb-05-00677-g0004){#F4}

Genomic context of the functional pneumococcal TAs *relBE2* and *pezAT*, and their distribution in *S. pneumoniae* population
-----------------------------------------------------------------------------------------------------------------------------

The distribution of functional TAs showed a very good correlation with pneumococcal STs and CCs (Table [2](#T2){ref-type="table"}). As described in our previous report, RelBE2 is present in all the 48 pneumococcal database strains with seven out of them having two copies. Moreover, six different gene organizations were found for this TA (Chan et al., [@B5]) that fall into two groups, encompassing the previously defined Types I-IV and Types V-VI (Chan et al., [@B5]; Figure [5A](#F5){ref-type="fig"}). The latter are flanked by xre upstream and COG2856B downstream, an arrangement that is not observed in Types I-IV. RelE2 of Types V and VI were also clustered together in the phylogenetic analyses (Figure [5B](#F5){ref-type="fig"}). In addition, in strains with two copies of RelBE2, one copy belonged to Types I-IV whereas the second copy belonged to either Type V or VI. Integrases and IS elements were evident in Types III-VI. The particular gene arrangement showed also a very good agreement with STs and CCs, with a single exception in the Taiwan^19F^-14 international clone (Table [2](#T2){ref-type="table"}). All these observations suggest that the second copy of *relBE2* may likely be horizontally acquired by some strains rather than represent a product of gene duplication.

![**Gene organization and phylogenetic analyses of pneumococcal RelE2 homologs. (A)** Polymorphisms associated with the gene organization of *relBE2* and their neighboring genes found in 48 pneumococcal strains. Six variations of gene organizations were found (Type I--VI). In general, the *relBE2* operon was flanked upstream by *vicX* (metal-dependent hydrolase), whereas a RUP ([r]{.ul}epeat [u]{.ul}nit of [p]{.ul}neumococcus), element, *ldh* (lactate dehydrogenease), and *gyrA* (the A subunit of DNA gyrase) are located downstream for Type I--IV. For Type V--VI, the *relBE2* cassette is flanked upstream by *xre*-like protein and COG2856B downstream. Mobile elements are seen in Types III--VI. Other abbreviations used: restriction-modification (RM); restriction-endonuclease (RE); hypothetical protein (HP). **(B)** Phylogenetic analyses of RelE2 homologs with neighbor-joining algorithm, in which the determined start codon of *relE2* was considered (Moreno-Córdoba et al., [@B48]), had shown that Type V and Type VI gene organizations of RelE2 cluster together, indicating RelE2 from both types are of more similar in sequences. The type of *relBE2* gene organization was indicated. For the strain Canada MDR 19F, the type of gene arrangement is unknown due to data unavailability in the NCBI databases.](fmicb-05-00677-g0005){#F5}

In our previous bioinformatics search, 28 out of the 48 annotated pneumococcal strains harbored a single copy of *pezAT*; whereas three strains harbored two copies (Chan et al., [@B5]). The two copies of *pezAT* within the same strain were almost identical (similarities of 96--97%), and the catalytically important residues (Meinhart et al., [@B47]) were also conserved. The gene organization of *pezAT* among the various *S. pneumoniae* strains is even more varied than *relBE2*. This TA is flanked by a number of genes that contribute to site-specific recombination and even genes that play roles in conjugative transfer. The *pezAT* locus is known to be present on a genomic island known as the pneumococcal pathogenicity island 1 (Meinhart et al., [@B47]; Nieto et al., [@B52]) but interestingly, a search using a web-based resource for bacterial ICEs known as ICEberg database led us to discover the presence of a previously unreported *pezAT* operon in a putative pneumococcal ICE designated Tn*5253* (Ayoubi et al., [@B1]). This was corroborated when a recent analysis of the complete sequence of Tn*5253* from *S. pneumoniae* DP1322 indicated the presence of two copies of *pezAT* (Iannelli et al., [@B29]) which comprised part of a 1169 bp direct repeat that flanks the Ω *cat*(pC194) element within Tn*5253*. Experimental evidence showed that excision of Ω *cat*(pC194) from Tn*5253* occurred by a recombination event within the *pezAT*-containing repeat segment leaving one copy in Tn*5253* and another copy in the newly-excised plasmid pC194 (Iannelli et al., [@B29]). Besides that, ectopic integration of Ω *cat*(pC194) to other regions of the *S. pneumoniae* genome was also detected, likely by homologous recombination involving the *pezAT*-containing direct repeat segments (Iannelli et al., [@B29]). Thus, *pezAT* appeared to play a direct role in the transfer of the Ω *cat*(pC194) element and may also help in the stable maintenance of this element in its hosts. It is therefore not surprising that phylogenetic analyses showed that PezAT found in Tn*5253* formed a separate cluster from PezAT located in the pneumococcal pathogenicity island 1 (Supplementary Figure [S2](#SM3){ref-type="supplementary-material"} and Table [S1](#SM1){ref-type="supplementary-material"}).

Conclusions
-----------

Previous searches for putative type II TAs in *S. pneumoniae* (Chan et al., [@B5], [@B6]) led us to conclude that their number was greatly undervalued. However, our present *in vivo* validation has shown that, indeed, only four of the TAs, namely RelBE2 (Nieto et al., [@B52]), YefM-YoeB (Nieto et al., [@B51]; Chan et al., [@B7]), PezAT (Khoo et al., [@B34]; Mutschler et al., [@B49]) and now, Phd-Doc can be considered as *bona fide* TAs in the "classical" sense that the harmful effects of the toxins must be counteracted by their cognate antitoxins and that their two genes should be organized as an operon (Gerdes, [@B22]). Bioinformatics search approaches have helped us to identify various putative TA homologs; however, the actual number of *bona fide* TAs might be overestimated as in our case e.g., pneumococcal *relBE2* is functional TA but pneumococcal *relBE1* is apparently not. In the case of *M. tuberculosis*, of the 88 putative TAs identified, only 30 are functional (Ramage et al., [@B56]). Other approaches like shotgun cloning as presented by Sberro et al. ([@B62]) could be another alternative and more thorough approach to identify TAs. However, there might be more TAs than these four if we consider Ant and Bro as possible solo toxins whose respective antitoxins might be located elsewhere in the pneumococcal chromosome. The finding that these two novel proteins might be associated with lysogenic bacteriophages is, indeed, appealing and merits an in-depth study of their features.
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